NR5A2 + LRH1 Antikörper (AA 328-338)

Produktnummer ABIN2851820

Produktdetails anti-NR5A2 + LRH1 Antikörper

Target: NR5A2 + LRH1 (NR5A2) (Nuclear Receptor Subfamily 5, Group A, Member 2 (NR5A2))

Bindungsspezifität: AA 328-338

Reaktivität: Human

Wirt: Ziege

Klonalität: Polyklonal

Konjugat: Dieser NR5A2 + LRH1 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Verwendungszweck: NR5A2 / LRH1 (aa328-338)

Sequenz: QEQANRSKHE K

Spezifität: This antibody is expected to recognize both reported isoforms (NP_995582.1, NP_003813.1).

Homologie: Human

Aufreinigung: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Güteklasse: Verified

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise:

DS WB Results: Approx 55 kDa band observed in lysates of cell line HepG2 (calculated MW of 56.5 kDa according to NP_003813.1). Recommended concentration: 1-3 μg/mL. Primary incubation was 1 hour.

DS IHC Results: Paraffin embedded Human Placenta. Recommended concentration: 5 μg/mL.

Peptide ELISA: antibody detection limit dilution 1:128000.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: Minimize freezing and thawing.

Lagerung: -20 °C

Informationen zur Lagerung: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Details zu NR5A2 + LRH1

Target: NR5A2 + LRH1 (NR5A2) (Nuclear Receptor Subfamily 5, Group A, Member 2 (NR5A2))

Andere Bezeichnung: NR5A2 (NR5A2 Produkte)

Synonyme: xff1rashort antikoerper, NR5A2 antikoerper, b1f antikoerper, b1f2 antikoerper, cpf antikoerper, ff1r antikoerper, ftf antikoerper, ftz-f1 antikoerper, ftz-f1beta antikoerper, hb1f antikoerper, hb1f-2 antikoerper, lrh-1 antikoerper, lrh1 antikoerper, xff1ra antikoerper, B1F antikoerper, B1F2 antikoerper, CPF antikoerper, FTF antikoerper, FTZ-F1 antikoerper, FTZ-F1beta antikoerper, LRH-1 antikoerper, LRH1 antikoerper, hB1F-2 antikoerper, xFF1rB antikoerper, AU020803 antikoerper, D1Ertd308e antikoerper, Ftf antikoerper, UF2-H3B antikoerper, Lrh-1 antikoerper, nuclear receptor subfamily 5 group A member 2 S homeolog antikoerper, nuclear receptor subfamily 5 group A member 2 antikoerper, nuclear receptor subfamily 5 group A member 2 L homeolog antikoerper, nuclear receptor subfamily 5, group A, member 2 antikoerper, nr5a2.S antikoerper, NR5A2 antikoerper, nr5a2 antikoerper, nr5a2.L antikoerper, Nr5a2 antikoerper

Hintergrund: NR5A2, nuclear receptor subfamily 5, group A, member 2, B1F, B1F2, CPF, FTF, FTZ-F1, FTZ-F1beta, LRH-1, LRH1, hB1F-2, CYP7A promoter-binding factor, alpha-1-fetoprotein transcription factor, b1-binding factor, hepatocyte transcription factor which activates enhancer II of hepatitis B virus, fetoprotein-alpha 1 (AFP) transcription factor, hepatocytic transcription factor, liver nuclear receptor homolog-1 variant 2, liver receptor homolog 1, liver receptor homolog-1, nuclear receptor NR5A2, nuclear receptor subfamily 5 group A member 2

Gen-ID: 2494

NCBI Accession: NP_995582, NP_003813

Pathways: Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway